Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Short-term Investments (2018 - 2023)

Acro Biomedical has reported Short-term Investments over the past 3 years, most recently at $4230.0 for Q3 2023.

  • Quarterly results put Short-term Investments at $4230.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $4230.0 (changed N/A YoY), and the annual figure for FY2019 was $4992.0, changed.
  • Short-term Investments for Q3 2023 was $4230.0 at Acro Biomedical, roughly flat from $4230.0 in the prior quarter.
  • Over the last five years, Short-term Investments for ACBM hit a ceiling of $4992.0 in Q1 2019 and a floor of $4230.0 in Q1 2023.